Latest Breaking News On - Astrazeneca tagrisso - Page 1 : vimarsana.com

MARKET REPORT: Wall Street Failure Sends Stocks Down 99%

In a dramatic session, the New York Stock Exchange said it was investigating a fault that led to trading in at least 60 companies to be halted.

Incredible hope for lung cancer patients as doctors reveal new drugs are adding years to people's lives

A new set of targeted and immune-boosting drugs can add months or even years to life expectancy according to results released this weekend at a top conference.

AstraZeneca's Tagrisso greatly slows cancer for some people with stage 3 lung cancer

ASCO 24: Data shows survival benefit with J&J's subcutaneous Rybrevant

J&J's Rybrevant is expected to generate $4bn in sales by 2030, as per GlobalData estimates.

ASCO24: Akeso's bispecific vvonescimab faces a rocky road ahead in NSCLC

While commercial uptake may be difficult for ivonescimab, a positive regulatory decision would help validate Akeso's bispecific platform.

ASCO: Novartis' Scemblix proves edge over predecessor Gleevec in newly diagnosed leukemia

Pfizer wins cancer drug patent case against AstraZeneca

The jury found that AstraZeneca's Tagrisso violated Pfizer's Wyeth unit's patent rights.

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute - AstraZeneca (NASDAQ:AZN), Pfizer (NYSE:PFE)

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

Trial for AstraZeneca's lung cancer drug Tagrisso points to increased survival rate